Dudediligence.

NEXGEL, Inc

NXGLNASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

9.70M

on 2026-06-30, from 6.23M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

$100.0M

Agreement of 2026-03-06. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

387.75M

Warrants of every class as tagged in the XBRL facts on 2024-12-31. 10-K ↗

Cash

2.1 quarters

$1.7M on 2026-06-30 ÷ $801K a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-05-15Private placement1,008,334not read$1.2M8-K ↗
2026-04-17Private placement5,750,000not read$6.9M8-K ↗
2026-02-09Private placementnot readnot read$1.8M8-K ↗
2025-08-01Public offering413,044$2.30$950K424B5 ↗
2025-07-31Registered direct offering206,522not read$950K8-K ↗

Also on file: $1.8M convertible notes, 2026-02-10 424B5 ↗